http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#Head http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#assertion http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#provenance http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#pubinfo http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#assertion http://purl.obolibrary.org/obo/DOID_4450 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_4450 http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00398 http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association http://www.w3.org/2000/01/rdf-schema#label nexavar is a kinase inhibitor indicated for the treatment of 1 1 1 2 1 3 nexavar r nexavar is indicated for the treatment of patients with advanced renal cell carcinoma rcc nexavar is indicated for the treatment of patients with locally recurrent or metastatic progressive differentiated thyroid carcinoma dtc that is refractory to radioactive iodine treatment http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00398 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#provenance http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#pubinfo http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#sig http://purl.org/nanopub/x/hasSignature B2ez15TlBiRJGlCA1gUAOoJSnFQi5T4PWCgEO/7LEbj0s36h40JP63/O3Abn9nPciVJtNCf8uJrNjp3ETcZSAPssy70yZ05VYg507t6dmgd760dq8A9SrsaPtJKTCUkPeKesUqPJlJyjxKnDI8B10LpxxnOs8ZNA2oYKTpBS+gA= http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://purl.org/dc/terms/created 2021-06-12T15:49:38.945+02:00 http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAlMbRF28zz4RwDaPXAOxzVHJGUsd8gbQsbNWB05mXOWY https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs